Serological Differences in Folate/Vitamin B12 in Pregnancies Affected by Neural Tube Defects
Authors:
- Irina CechICIrina Cech
- Keith D. BurauKBKeith D. Burau
- 1 May 2010
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 103 (5) , 419-424
Abstract
Laboratory evidence is presented of significant associations between reduced maternal serum folate and vitamin B12 levels and neural tube birth defects (NTD) compared to referents. This was an incident case-control study. Cases of neural tube defects (including anencephaly and open spina bifida) diagnosed in residents within 100 miles of the US-Mexico border from January 1993 to October 2000 were eligible. Most cases were diagnosed in utero upon visits to clinics, obstetrical or genetic expert offices. Cases identified upon hospital admission or at delivery were also eligible. Cases identified after discharge were not. Controls were matched on geographic region, maternal age, race/ethnicity, gestational age, and type of health insurance (including none). Three hundred eighty-two border area residents (107 cases and 275 individually matched controls) provided biological specimens. Median folate concentrations for case mothers were 36% lower than controls (9.8 ng/mL vs. 15 ng/mL). Maternal serum folate concentrations in quartiles above 9.5 ng/mL indicated significantly reduced risk (OR = 0.4, OR = 0.3, and OR = 0.2). Likewise, the risk for NTD decreased (OR = 0.4, OR = 0.3, and OR = 0.2) in quartiles of sera B12 concentrations above 246 pg/mL. Physician attention is invited to significantly lower concentrations of serum folate and vitamin B12 in women with NTD-affected pregnancies. This study assayed sera samples from women while still pregnant or immediately after delivery. The confounding effect of reduced folate and B12 levels with other biological and chemical exposures will be addressed in subsequent communications.Keywords
This publication has 10 references indexed in Scilit:
- Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controlsPediatric Surgery International, 2008
- Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifidaAmerican Journal of Medical Genetics, 2002
- Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube DefectsJAMA, 2001
- Neural Tube Defects among Mexican Americans Living on the US-Mexico Border: Effects of Folic Acid and Dietary FolateAmerican Journal of Epidemiology, 2000
- Decline in Prevalence of Neural Tube Defects in a High-Risk Region of the United StatesPediatrics, 2000
- Population-based case control study of folic acid supplementation during pregnancyTeratology, 1996
- Blood folic acid and vitamin B12 in relation to neural tube defectsBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTSEpidemiology, 1995
- Investigation of factors influencing folate status in women who have had a neural tube defect‐affected infantBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western AustraliaMedical Journal of Australia, 1989